Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.

Papamichael K, Chachu KA, Vajravelu RK, Vaughn BP, Ni J, Osterman MT, Cheifetz AS.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1580-1588.e3. doi: 10.1016/j.cgh.2017.03.031. Epub 2017 Mar 30.

2.

How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.

Chachu KA, Osterman MT.

Inflamm Bowel Dis. 2016 May;22(5):1262-74. doi: 10.1097/MIB.0000000000000726. Review.

PMID:
26891261
3.

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.

Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW.

PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.

4.

Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.

Purtha WE, Chachu KA, Virgin HW 4th, Diamond MS.

J Virol. 2008 Nov;82(22):10964-74. doi: 10.1128/JVI.01646-08. Epub 2008 Sep 10.

5.

Antibody is critical for the clearance of murine norovirus infection.

Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW 4th.

J Virol. 2008 Jul;82(13):6610-7. doi: 10.1128/JVI.00141-08. Epub 2008 Apr 16.

6.

Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence.

Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER, Henderson KS, Kelley ST, Virgin HW 4th.

J Virol. 2007 Oct;81(19):10460-73. Epub 2007 Jul 25.

7.

Genetic composition of the Bacillus subtilis SOS system.

Au N, Kuester-Schoeck E, Mandava V, Bothwell LE, Canny SP, Chachu K, Colavito SA, Fuller SN, Groban ES, Hensley LA, O'Brien TC, Shah A, Tierney JT, Tomm LL, O'Gara TM, Goranov AI, Grossman AD, Lovett CM.

J Bacteriol. 2005 Nov;187(22):7655-66.

Supplemental Content

Loading ...
Support Center